Specifically, CB1R activation has been associated with increased TNFα secretion in human bladder carcinoma cells,28 whereas CB1R antagonism was reported to inhibit TNFα production in the inflamed small intestine in rats.29 The gene discussed is TNF; the disease is urinary bladder carcinoma.